INTRODUCTION
Fine Needle Aspiration Cytology (FNAC) is a safe, reliable and cost effective tool that is used in the diagnosis of lesions in various organs. The diagnostic accuracy has significantly improved recently due to cytopathologists accumulating experience with this method and with the advent of diagnostic radiologic modalities. Many recent studies on FNAC for diagnosing neoplastic lesions with an epithelial origin and reactive lesions, including lymph nodes, indicate that it has a satisfactory diagnostic accuracy. 1 Soft tissue arises from the non-epithelial extra skeletal connective tissue exclusive of the reticuloendothelial system, glia and supporting tissue of various parenchymal organs.
FNAC is considered to be of limited value in the diagnosis of soft tissue tumors in comparison with organs like breast and thyroid. Most clinicians dealing with such a lesion are reluctant to accept FNAC diagnosis in determining the treatment modality, chiefly in view of the poor morphological expression in aspirates and the limited individual experience of the cytopathologist because of the low incidence of sarcoma. Nevertheless the cytologic and architectural findings published over the last few years, taken in conjunction with clinical and radiological data, enable cytologic diagnosis to be as precise as those reached through histologic examination in experienced hands. FNAC is an outpatient department procedure necessitating neither patient preparation nor general anesthesia. It has minimal risk of complications such as bleeding or infection and the risk of tumor spread is negligible. 3 With the above background, the present study is undertaken to study the nature of various soft tissue tumors by FNAC and to compare the cytologic diagnosis with the results obtained by biopsy and thus assessing the diagnostic accuracy of FNAC for soft tissue tumors.
METHODS
The present prospective study was carried out in 217 patients who were selected from those attending the surgery, orthopedics, pediatrics and cancer outpatient departments of the Pt. J. N. M. medical college, Raipur (C. All cases (713) included in present series were taken up for study, irrespective of their age and sex. The history was elucidated as per predesigned proforma and the presenting complaints with their duration were noted in chronological order. Local examination of the swelling was done carefully and the fine needle aspiration was performed on patients with palpable soft tissue lesions.
Ethical considerations were met through institutional ethical committee. Aspiration of soft tissue lesions were performed following the technique of Zajicek et al. 4 Smear was prepared and wet fixed smears were stained with papanicolaou and haematoxylin and eosin stain and air dried smears were stained with May GrunwaldGiemsa (MGG) stain. 5 After the FNAC is being done, all the cases were followed up as far as possible. Histopathological findings were available in 140 cases. Data was compiled in MS excel and checked for its completeness, correctness and then it was analyzed. Out of the total 713 cases of soft tissue tumors, 71.25% were reported as benign and 28.75% as malignant. M:F was 1.63:1. The peak age group for benign soft tissue tumors was 20-40 years, whereas malignant soft tissue tumors were more common in children and young adults ( Table 2) . Benign soft tissue tumors were roughly equally distributed across all parts of the body. Lipomas were predominantly seen in the upper extremity, head and neck and back (57.38%). The commonest site of involvement for the malignant soft tissue tumors was lower extremity (41%) ( Table 4) . In the present study, of the 11,560 cases of FNAC done during this period, 6.16% (713 cases) were diagnosed as soft tissue tumors on cytology. Bezabih M, 6 Roy et al. 3 and Dey et al. 7 found the incidence 4.1%, 2.59% and 4.94% respectively in their studies.
RESULTS

Total
In this study out of total 713 cases, 71.25% were benign and 28.75% were malignant lesions. This is in concordance with the findings of Roy et al. 3 who reported 79.14% benign and 20.86% as malignant lesions. Dey et al. 7 reported 83.70% as benign and 16.30% as malignant. Almost similar findings were noted by Bezabih M 6 and Roy S et al. 8 In the current study, the peak age group was 20-40 years for benign soft tissue tumors. This is in concordance with study of Roy S et al. 8 who observed that benign tumors were relatively common above third decade. The more common age group sharing the burden of malignant soft tissue tumors were being children and young adults comprising of 75.12%. This is in concordance with the studies of Pallock et al., 9 Bezabih M 6 and Roy S et al. 8 who observed that soft tissue sarcomas were relatively more common in young adults.
In this study, male patients outnumbered the female patients in both benign and malignant categories with M:F-1.63:1. Roy S et al., 8 Rekhi et al. 10 Barth et al. 11 and Wakely et al. 12 found almost similar results with M:F of 1.65:1, 1.82:1, 1.47:1 and 1.5:1 respectively.
In the present study, lipomas 79.9%, neural 5.9% and vascular tumors 5.7% formed the main chunk of benign lesions. This is in keeping with the findings of Layfield et al. 13 who reported 78.9% soft tissue tumor as lipoma and 9.6% each of vascular and neural tumors. Bezabih M 6 reported 70.5% as lipomas and 8.9% neurogenic tumors. Roy et al 3 and Roy S et al. 8 reported lipomas, neural and vascular tumors as 47.2%, 13.9%, 32.9% and 36.9%, 27.9%, 9.2% respectively.
In the current study, round cell sarcoma and rhabdomyosarcoma together constituted (43.9%) cases, followed by spindle cell sarcoma (22.4%), and pleomorphic sarcoma (6.8%). Malignant mesenchymal lesion that could not be otherwise specified also constituted a major group (26.34%) cases. This is in keeping with the findings of Roy et al. 3 who also reported a higher incidence of rhabdomyosarcoma and undifferentiated round cell sarcomas 58.6%, and synovial sarcoma (categorized under spindle cell) and pleomorphic sarcoma were reported as 14.65% and 6.89% respectively. Rekhi et al. 10 reported spindle cell type as the major group constituting 43.6% of malignant tumors, followed by 31.7% of round cell and 11.9% of pleomorphic tumors.
In the present study, benign soft tissue tumors were equally distributed across all parts of the body. The more common site of involvement for the lipomas are upper extremity, head and neck and back (57.38%). Neural tumors and vascular tumors were more common in upper extremity (36.66%) and head and neck (55.77%) region respectively. This is in keeping with the findings of Bezabih M 6 who observed benign tumors were almost equally distributed across all parts, with a slight predilection for head and neck 26.2% and the trunk region 26.4%, especially for the lipomas. Roy et al. 3 reported that lipoma was more common on back, chest wall, upper extremity and vascular hamartomas on lower extremity and neck whereas neurofibromas were evenly distributed.
In this study, it was noticed that the commonest site of involvement of malignant soft tissue tumors was the lower extremity (41%). Spindle cell, round cell and pleomorphic sarcomas were found predominantly on lower extremity comprising 52.17%, 33.3% and 57.1% respectively. However, rhabdomyosarcoma was more common in head and neck (37.5%) followed by lower extremity (29.16%) and abdomen (16.66%). This is in concordance with the findings of Roy et al., 3 who also reported lower extremity as the common site for synovial and round cell sarcomas, 75% and 40.9% respectively. They also observed that rhabdomyosarcoma was more common on face and skull (34.68%) followed by lower extremity (21.73%) and abdomen (17.39%) which is in accordance with this study. Bezabih M, 6 Rekhi et al. 10 and Fletcher et al 14 observed lower extremities (most common in thigh) as the commonest site of involvement of malignant tumors which is also in keeping with findings of the present study.
In the current study, diagnostic accuracy rate for benign and malignant tumors was found to be 88.1% and 92.9% respectively with overall accuracy rate of 90%. This is in concordance with the studies of Roy S et al. 8 and Bezabih M 6 in which accuracy rates were 90.8% and 84.9% respectively. Rasool et al. 15 observed the diagnostic accuracy rate for benign and malignant soft tissue lesions to be 94.38% and 100% respectively. Sampling error accounts for the majority of discordant cases (10%) in soft tissue tumors in the present study. A case of lipoma was misdiagnosed as hemangioma probably due to local bleeding during aspiration. One misdiagnosis of neurofibroma given on cytology later proved to be hemangioma after histopathological examination. Paucicellular smears predominantly composed of blood cells and occasional aggregate of bland appearing spindle shaped endothelial cells and fibroblasts set within collagenous matrix led to misdiagnosis. A soft lesion on the wrist cytologically misdiagnosed as lipoma as the highly characteristic ghost cells of pilomatrixoma were not observable due to their poor affinity with the stain and the presence of amorphic cellular remains. One case of myxoma was misdiagnosed as schwannoma in view of extensive myxoid changes.
In the present study, there were 6 false negative cases on FNAC. A deep seated fibrosarcoma of thigh was missed altogether by the aspiration and the cells aspirated from the surrounding adipose tissue led to misdiagnosis of lipoma. Hypocellular aspirate smear from thigh was seriously misleading in a case of round cell sarcoma which was originally misclassified as lipoma. A case of malignant peripheral nerve sheath tumor was misdiagnosed as benign nerve sheath tumor as the cellularity on the FNAC smear was much less and the cells showed minimal pleomorphism. Two cases of dermatofibrosarcoma protuberans were misdiagnosed as peripheral nerve sheath tumor as the cell clusters comprised of uniform spindle cells embedded in collagenous/fibrillary matrix. Klijanieko J et al. 16 and Domanski HA et al. 17 also pointed out the difficulty in making a correct cytological diagnosis from smears alone, concluding that "the role of FNA in the differential diagnosis of Dermatofibrosarcoma protruberans from a variety of other spindle cell tumors in terms of malignancy and accurate diagnosis is limited". A case of fibrosarcoma was misdiagnosed as benign mesenchymal lesion as the aspirate represented only benign portion and completely missed the malignant portion. Dahl I et al. 18 also found this pitfall in their study and emphasized that multiple aspirations from different sites would be helpful in these cases.
There were four false positive cases (7.14%) in the present study which represents the limitation and challenges in FNAC interpretation of low grade lesions. The presence of degenerate atypical cells misled in a case of schwannoma which was misdiagnosed as spindle cell sarcoma. These degenerate atypical cells have also been described by Hook et al. 19 and Dey et al. 7 A rapidly enlarging cellular hemangioma was misdiagnosed as sarcoma in view of highly cellular smears comprised predominantly of elongated spindled cells arranged in three dimensional coils and arcades. Another case of neurofibroma which was misdiagnosed as malignant, contained only scattered moderately pleomorphic cells. FNAC from a case of retroperitoneal paraganglioma showing cellular bloody smears with discrete cells and loose clusters of large spindled pleomorphic cells with anisonucleosis and a few larger cells with irregular nuclei and coarser chromatin was misdiagnosed as sarcoma. Cytologic features of paraganglioma are diverse. To avoid misdiagnosing these lesions as malignancies, paraganglioma should be added to the differential diagnosis list when dealing with retroperitoneal FNAC.
CONCLUSION
The overall diagnostic accuracy of FNAC in the present study was found 90% which is at par with other studies. FNAC is a safe, cost effective and reliable method to diagnose benign and malignant soft tissue tumors and in most instances histological sub typing is possible. Clearly, attention should be given to specimen adequacy, with some minimal requirement for cellularity before issuing a report. This would improve the accuracy and reliability of FNAC of these lesions.
Thus to conclude, FNAC in routine evaluation of soft tissue tumors requires understanding advances and limitations of aspiration cytology, identification of potential pitfalls, and optimizing of ancillary methods necessary for accurate diagnosis.
